Literature DB >> 26168252

A rapid spin through oil results in higher cell-associated concentrations of antiretrovirals compared with conventional cell washing.

Theodore J Cory1, Lee C Winchester1, Brian L Robbins1, Courtney V Fletcher1.   

Abstract

BACKGROUND: Determination of cell-associated antiretroviral drug concentrations is necessary for research into reservoirs of HIV. Variation exists in cell-associated drug concentrations among research groups. One cause for this may be washing cells during processing. We explored spinning cells through oil to minimize this variability. METHODS &
RESULTS: Raltegravir, atazanavir, darunavir, efavirenz, lopinavir and ritonavir concentrations were assessed in CEM.ss T cells washed with HBSS and oil-spun cells. Oil-spun cells had significantly higher concentrations for all drugs compared with samples washed with HBSS.
CONCLUSION: The decline in cell-associated drug concentrations with saline washes compared with a single spin through oil shows the utility of a spin through oil. Oil centrifugation results in high cell-associated drug concentrations, and can be done in a fast, efficient manner.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26168252      PMCID: PMC4512735          DOI: 10.4155/bio.15.70

Source DB:  PubMed          Journal:  Bioanalysis        ISSN: 1757-6180            Impact factor:   2.681


  21 in total

1.  CONTINUOUS CULTURE OF HUMAN LYMPHOBLASTS FROM PERIPHERAL BLOOD OF A CHILD WITH ACUTE LEUKEMIA.

Authors:  G E FOLEY; H LAZARUS; S FARBER; B G UZMAN; B A BOONE; R E MCCARTHY
Journal:  Cancer       Date:  1965-04       Impact factor: 6.860

2.  Intracellular efavirenz levels in peripheral blood mononuclear cells from human immunodeficiency virus-infected individuals.

Authors:  Rie Tanaka; Hideji Hanabusa; Ei Kinai; Naoki Hasegawa; Masayoshi Negishi; Shingo Kato
Journal:  Antimicrob Agents Chemother       Date:  2007-12-10       Impact factor: 5.191

3.  Quantification of cell-associated atazanavir, darunavir, lopinavir, ritonavir, and efavirenz concentrations in human mononuclear cell extracts.

Authors:  Anthony T Podany; Lee C Winchester; Brian L Robbins; Courtney V Fletcher
Journal:  Antimicrob Agents Chemother       Date:  2014-03-10       Impact factor: 5.191

4.  Intracellular and plasma pharmacokinetics of efavirenz in HIV-infected individuals.

Authors:  Lisa M Almond; Patrick G Hoggard; Damitha Edirisinghe; Saye H Khoo; David J Back
Journal:  J Antimicrob Chemother       Date:  2005-09-01       Impact factor: 5.790

5.  A rapid technique for separation of thymocytes from suspensions by centrifugation through silicone oil.

Authors:  P A Andreasen; B P Schaumburg; K Osterline; J Vinten; S Gammeltoft; J Gliemann
Journal:  Anal Biochem       Date:  1974-06       Impact factor: 3.365

6.  Influence of atazanavir 200 mg on the intracellular and plasma pharmacokinetics of saquinavir and ritonavir 1600/100 mg administered once daily in HIV-infected patients.

Authors:  Jennifer Ford; Marta Boffito; Desmond Maitland; Andrew Hill; David Back; Saye Khoo; Mark Nelson; Graeme Moyle; Brian Gazzard; Anton Pozniak
Journal:  J Antimicrob Chemother       Date:  2006-09-19       Impact factor: 5.790

7.  Intracellular accumulation of human immunodeficiency virus protease inhibitors.

Authors:  Saye H Khoo; Patrick G Hoggard; Ian Williams; E Rhiannon Meaden; Philippa Newton; Edmund G Wilkins; Alan Smith; John F Tjia; Judy Lloyd; Kevin Jones; Nick Beeching; Peter Carey; Barry Peters; David J Back
Journal:  Antimicrob Agents Chemother       Date:  2002-10       Impact factor: 5.191

8.  Discrepancies between protease inhibitor concentrations and viral load in reservoirs and sanctuary sites in human immunodeficiency virus-infected patients.

Authors:  Caroline Solas; Alain Lafeuillade; Philippe Halfon; Stéphane Chadapaud; Gilles Hittinger; Bruno Lacarelle
Journal:  Antimicrob Agents Chemother       Date:  2003-01       Impact factor: 5.191

9.  Intracellular indinavir pharmacokinetics in HIV-infected patients: comparison with plasma pharmacokinetics.

Authors:  Martina Hennessy; Susan Clarke; J Paul Spiers; Fiona Mulcahy; Dermot Kelleher; Emma Meadon; Bridget Maher; Colm Bergin; Saye Khoo; John Tjia; Patrick Hoggard; David Back; Michael Barry
Journal:  Antivir Ther       Date:  2003-06

10.  DrugBank 4.0: shedding new light on drug metabolism.

Authors:  Vivian Law; Craig Knox; Yannick Djoumbou; Tim Jewison; An Chi Guo; Yifeng Liu; Adam Maciejewski; David Arndt; Michael Wilson; Vanessa Neveu; Alexandra Tang; Geraldine Gabriel; Carol Ly; Sakina Adamjee; Zerihun T Dame; Beomsoo Han; You Zhou; David S Wishart
Journal:  Nucleic Acids Res       Date:  2013-11-06       Impact factor: 16.971

View more
  9 in total

Review 1.  Direct and indirect quantification of phosphate metabolites of nucleoside analogs in biological samples.

Authors:  Nagsen Gautam; Jawaher Abdullah Alamoudi; Sushil Kumar; Yazen Alnouti
Journal:  J Pharm Biomed Anal       Date:  2019-10-03       Impact factor: 3.935

Review 2.  HIV Persistence in Gut-Associated Lymphoid Tissues: Pharmacological Challenges and Opportunities.

Authors:  Corbin G Thompson; Cynthia L Gay; Angela D M Kashuba
Journal:  AIDS Res Hum Retroviruses       Date:  2017-05-16       Impact factor: 2.205

3.  The Effect of Rifampicin on Darunavir, Ritonavir, and Dolutegravir Exposure within Peripheral Blood Mononuclear Cells: a Dose Escalation Study.

Authors:  Amedeo De Nicolò; Andrea Calcagno; Ilaria Motta; Elisa De Vivo; Antonio D'Avolio; Giovanni Di Perri; Lubbe Wiesner; Isma-Eel Ebrahim; Gary Maartens; Catherine Orrell; Helen McIlleron
Journal:  Antimicrob Agents Chemother       Date:  2022-05-18       Impact factor: 5.938

4.  Plasma and intracellular pharmacokinetics of tenofovir in patients switched from tenofovir disoproxil fumarate to tenofovir alafenamide.

Authors:  Anthony T Podany; Sara H Bares; Joshua Havens; Shetty Ravi Dyavar; Jennifer O'Neill; Sarah Lee; Courtney V Fletcher; Susan Swindells; Kimberly K Scarsi
Journal:  AIDS       Date:  2018-03-27       Impact factor: 4.177

Review 5.  The Lymph Node Reservoir: Physiology, HIV Infection, and Antiretroviral Therapy.

Authors:  Erin M B Scholz; Angela D M Kashuba
Journal:  Clin Pharmacol Ther       Date:  2021-02-28       Impact factor: 6.875

6.  Antiretroviral Therapy Concentrations Differ in Gut vs. Lymph Node Tissues and Are Associated With HIV Viral Transcription by a Novel RT-ddPCR Assay.

Authors:  Sulggi A Lee; Sushama Telwatte; Hiroyu Hatano; Angela D M Kashuba; Mackenzie L Cottrell; Rebecca Hoh; Teri J Liegler; Sophie Stephenson; Ma Somsouk; Peter W Hunt; Steven G Deeks; Steven Yukl; Radojka M Savic
Journal:  J Acquir Immune Defic Syndr       Date:  2020-04-15       Impact factor: 3.771

7.  Distribution of fluoroquinolones in the two aqueous compartments of Escherichia coli.

Authors:  Ankit Pandeya; Olaniyi Alegun; Yuguang Cai; Yinan Wei
Journal:  Biochem Biophys Rep       Date:  2020-11-13

8.  Antiretroviral drug exposure in lymph nodes is heterogeneous and drug dependent.

Authors:  Elias P Rosen; Claire Deleage; Nicole White; Craig Sykes; Catherine Brands; Lourdes Adamson; Paul Luciw; Jacob D Estes; Angela D M Kashuba
Journal:  J Int AIDS Soc       Date:  2022-04       Impact factor: 6.707

9.  Tissue Pharmacologic and Virologic Determinants of Duodenal and Rectal Gastrointestinal-Associated Lymphoid Tissue Immune Reconstitution in HIV-Infected Patients Initiating Antiretroviral Therapy.

Authors:  David M Asmuth; Corbin G Thompson; Tae-Wook Chun; Zhong-Min Ma; Surinder Mann; Talia Sainz; Sergio Serrano-Villar; Netanya S Utay; Juan Carlos Garcia; Paolo Troia-Cancio; Richard B Pollard; Christopher J Miller; Alan Landay; Angela D Kashuba
Journal:  J Infect Dis       Date:  2017-10-17       Impact factor: 5.226

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.